Clinical Trials Browser

Phase 2/3 × Fluorodeoxyglucose F18 × Sarcoma × Clear all

NCT06820957 2026-02-17

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Phase 2/3 Active not recruiting

Sarcoma, Ewing